Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 23041 | 304 | 42.2 | 90% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 580 | 13536 | MICROSATELLITE INSTABILITY//LYNCH SYNDROME//HNPCC |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | KIAA1199 | Author keyword | 21 | 90% | 3% | 9 |
| 2 | MIR 188 5P | Author keyword | 2 | 67% | 1% | 2 |
| 3 | TRANSCRIPTOMIC PROFILES | Author keyword | 2 | 67% | 1% | 2 |
| 4 | WHOLE GENOMIC OLIGONUCLEOTIDE MICROARRAY | Author keyword | 2 | 67% | 1% | 2 |
| 5 | BIOCHEM BIOCHEM MOL MED | Address | 1 | 100% | 1% | 2 |
| 6 | NON NEOPLASTIC MUCOSA | Author keyword | 1 | 50% | 1% | 2 |
| 7 | MATRISOME | Author keyword | 1 | 40% | 1% | 2 |
| 8 | TAISHO FUNCT GENOMICS | Address | 1 | 33% | 1% | 2 |
| 9 | STAGE II COLON CANCER | Author keyword | 1 | 23% | 1% | 3 |
| 10 | 12 GENE ASSAY | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | KIAA1199 | 21 | 90% | 3% | 9 | Search KIAA1199 | Search KIAA1199 |
| 2 | MIR 188 5P | 2 | 67% | 1% | 2 | Search MIR+188+5P | Search MIR+188+5P |
| 3 | TRANSCRIPTOMIC PROFILES | 2 | 67% | 1% | 2 | Search TRANSCRIPTOMIC+PROFILES | Search TRANSCRIPTOMIC+PROFILES |
| 4 | WHOLE GENOMIC OLIGONUCLEOTIDE MICROARRAY | 2 | 67% | 1% | 2 | Search WHOLE+GENOMIC+OLIGONUCLEOTIDE+MICROARRAY | Search WHOLE+GENOMIC+OLIGONUCLEOTIDE+MICROARRAY |
| 5 | NON NEOPLASTIC MUCOSA | 1 | 50% | 1% | 2 | Search NON+NEOPLASTIC+MUCOSA | Search NON+NEOPLASTIC+MUCOSA |
| 6 | MATRISOME | 1 | 40% | 1% | 2 | Search MATRISOME | Search MATRISOME |
| 7 | STAGE II COLON CANCER | 1 | 23% | 1% | 3 | Search STAGE+II+COLON+CANCER | Search STAGE+II+COLON+CANCER |
| 8 | 12 GENE ASSAY | 1 | 50% | 0% | 1 | Search 12+GENE+ASSAY | Search 12+GENE+ASSAY |
| 9 | ADENOMA DYSPLASIA CARCINOMA SEQUENCE | 1 | 50% | 0% | 1 | Search ADENOMA+DYSPLASIA+CARCINOMA+SEQUENCE | Search ADENOMA+DYSPLASIA+CARCINOMA+SEQUENCE |
| 10 | ASSESSING PROGNOSIS | 1 | 50% | 0% | 1 | Search ASSESSING+PROGNOSIS | Search ASSESSING+PROGNOSIS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PROGNOSIS PREDICTION | 23 | 100% | 3% | 10 |
| 2 | HYALURONAN DEPOLYMERIZATION | 6 | 100% | 1% | 4 |
| 3 | PREDICTS RECURRENCE | 5 | 55% | 2% | 6 |
| 4 | KIAA1199 | 4 | 75% | 1% | 3 |
| 5 | II COLON CANCER | 4 | 14% | 8% | 23 |
| 6 | DUKES B | 3 | 11% | 9% | 26 |
| 7 | NONNEOPLASTIC MUCOSA | 2 | 24% | 3% | 8 |
| 8 | PREDICT RECURRENCE | 2 | 19% | 3% | 9 |
| 9 | TUMOR GENE EXPRESSION | 1 | 23% | 2% | 5 |
| 10 | INDEPENDENT VALIDATION | 1 | 33% | 1% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Gene expression profiling in colorectal cancer using microarray technologies: Results and perspectives | 2009 | 49 | 66 | 48% |
| Colorectal Cancer Heterogeneity and Targeted Therapy: A Case for Molecular Disease Subtypes | 2015 | 1 | 34 | 26% |
| Precision medicine - Delivering the goods? | 2014 | 0 | 2 | 50% |
| Personalized treatment for patients with colorectal cancer: role of biomarkers | 2015 | 1 | 81 | 20% |
| Microarray analysis to reveal genes involved in colon carcinogenesis | 2007 | 10 | 25 | 40% |
| An "Omics" based survey of human colon cancer | 2010 | 28 | 80 | 21% |
| DNA microarray-based gene expression profiling in diagnosis, assessing prognosis and predicting response to therapy in colorectal cancer | 2012 | 2 | 57 | 32% |
| Oncotype DX (R) colon cancer assay for prediction of recurrence risk in patients with stage II and III colon cancer: A review of the evidence | 2015 | 0 | 20 | 35% |
| Prognostic and Predictive Markers in Stage II Colon Cancer: Is There a Role for Gene Expression Profiling? | 2011 | 25 | 67 | 18% |
| Expression and genomic profiling of colorectal cancer | 2007 | 67 | 188 | 13% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BIOCHEM BIOCHEM MOL MED | 1 | 100% | 0.7% | 2 |
| 2 | TAISHO FUNCT GENOMICS | 1 | 33% | 0.7% | 2 |
| 3 | ARRAYS IMAGE | 1 | 50% | 0.3% | 1 |
| 4 | CANC GIOVANNI XXIII | 1 | 50% | 0.3% | 1 |
| 5 | GENOM TRANSLAT | 1 | 50% | 0.3% | 1 |
| 6 | MED OM INFORMAT | 1 | 50% | 0.3% | 1 |
| 7 | MEDCANC PATHOL MED | 1 | 50% | 0.3% | 1 |
| 8 | MRCCMT | 1 | 50% | 0.3% | 1 |
| 9 | OTAGO GENOM IL | 1 | 50% | 0.3% | 1 |
| 10 | S CAROLINA CANC BASIC | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000197515 | INTER SIMPLE SEQUENCE REPEAT PCR//BIOPHYS CYTOMETRY//HOSP UNIV SALAMANCA IBSAL |
| 2 | 0.0000125213 | PHILIP MORRIS INT RD//COMPUTAT PL GENOM PROGRAM//SECT COMPUTAT BIOMED |
| 3 | 0.0000104005 | PANITUMUMAB//CETUXIMAB//METASTATIC COLORECTAL CANCER |
| 4 | 0.0000096692 | COLONIC EFFLUENT//STOOL DNA//FECAL RNA |
| 5 | 0.0000083826 | SERRATED ADENOMA//SESSILE SERRATED ADENOMA//TRADITIONAL SERRATED ADENOMA |
| 6 | 0.0000076061 | MACC1//METASTASIS ASSOCIATED IN COLON CANCER 1//MACC 1 |
| 7 | 0.0000074790 | LY573636//TASISULAM//NCI 60 |
| 8 | 0.0000070933 | OXALIPLATIN//CAPECITABINE//IRINOTECAN |
| 9 | 0.0000069544 | OCCULT NEOPLASTIC CELLS//COMPLETE MESOCOLIC EXCISION//LYMPH NODE YIELD |
| 10 | 0.0000067375 | MICROARRAY IMAGE PROCESSING//GENE FILTERING//MAQC |